angiotensin ii has been researched along with Acquired Nephrogenic Diabetes Insipidus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, P; Kong, Y; Levi, M; Li, C; Li, S; Lin, Y; Liu, Q; Qiu, M; Wang, W; Zhang, T; Zheng, P | 1 |
| Schrier, RW | 1 |
2 other study(ies) available for angiotensin ii and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus.
Topics: Amides; Angiotensin II; Animals; Antihypertensive Agents; Aquaporin 2; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diabetes Insipidus, Nephrogenic; Drug Evaluation, Preclinical; Fumarates; Kidney Medulla; Kidney Tubules, Collecting; Lithium; Male; Mice, Inbred C57BL; Polyuria; Prorenin Receptor; Receptors, Cell Surface | 2017 |
Interactions between angiotensin II and arginine vasopressin in water homeostasis.
Topics: Adenylyl Cyclases; Angiotensin II; Animals; Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Phosphorylation; Polyuria; Receptor, Angiotensin, Type 1; Urine; Water-Electrolyte Balance | 2009 |